Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexesMarcus Bantscheff, Gerard Drewes, Carsten Hopf et al.|Nature Biotechnology|2011Cited by 666
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B. Pappalardi, Rab K. Prinjha, Jacques Briand et al.|Nature Cancer|2021Cited by 279
Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein HomeostasisMikhail M. Savitski, Marcus Bantscheff, Nico Zinn et al.|Cell|2018Cited by 226
The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET BromodomainsAntje Dittmann, Gerard Drewes, Thilo Werner et al.|ACS Chemical Biology|2013Cited by 114